The drugs show pharma at its best and its worst ... A drug for low libido, or 'acquired, generalised hypoactive sexual desire disorder' (HSDD) in premenopausal women, Addyi was approved in ...

With a diagnosis of FSIAD/HSDD, these "female Viagra" drugs may be an option. Your provider can explain the benefits and risks based on your situation and personal preferences.

The company’s lead product, the testosterone TEPI patch for HSDD in postmenopausal women ... support transdermal delivery of lower-potency drugs, in addition to reducing the size and thickness ...

HSDD is currently on the rise in adult women population ... Hence, the presence of pipeline drugs offers a lucrative opportunity for the LATAM women hypoactive sexual desire disorder treatment market.